CLINICAL TRIALS PROFILE FOR DEFINITY
✉ Email this page to a colleague
All Clinical Trials for DEFINITY
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00162058 ↗ | A Phase II Study of DMP 115 to Assess Focal Liver Lesions | Completed | Lantheus Medical Imaging | Phase 2 | 2004-03-01 | To determine the optimal dose of DMP 115 to image liver lesions and to assess whether contrast can improve the detection of focal liver lesions. |
| NCT00162370 ↗ | A Study of Stress Echocardiography in Post-Menopausal Women at Risk for Coronary Disease | Completed | Lantheus Medical Imaging | Phase 4 | 2004-04-01 | The study is designed to see if stress echocardiography can be used as a screening exam in peri-, or post-menopausal women with a risk of developing of coronary artery disease and experiencing future cardiac events. |
| NCT00239525 ↗ | 3-D Transcranial Ultrasound Analysis Study | Completed | Duke University | N/A | 2006-05-01 | The purpose of this study is to investigate real time 3-D ultrasound imaging of the brain for the diagnosis and evaluation of stroke. |
| NCT00401687 ↗ | DMP115 in Patients With an Ejection Fraction Between 25%-40% to Evaluate the Use of Contrast Echocardiography to Assess Heart Function | Completed | Lantheus Medical Imaging | Phase 4 | 2006-07-01 | The purpose of this clinical research study is to demonstrate the ability of Definity® enhanced versus unenhanced cardiac ultrasound to improve the accuracy and reproducibility of left ventricular ejection fraction (EF) when compared to magnetic resonance imaging (MRI). |
| NCT00507806 ↗ | Microbubble-Enhanced Clotbust Treatment of Acute Ischemic Stroke | Terminated | ImaRx Therapeutics | Phase 1/Phase 2 | 2005-03-01 | The study is designed to examine the safety, tolerability, and activity of a combination of microbubbles (perflutren lipid microsphere [Definity®]) and continuous monitoring with 2 MHz transcranial Doppler ultrasound (TCD) as an adjunctive therapy to tissue plasminogen activator (tPA) treatment in subjects with acute ischemic stroke. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for DEFINITY
Condition Name
Clinical Trial Locations for DEFINITY
Trials by Country
Clinical Trial Progress for DEFINITY
Clinical Trial Phase
Clinical Trial Sponsors for DEFINITY
Sponsor Name
